A Case of Phage Therapy against Pandrug-Resistant Achromobacter xylosoxidans in a 12-Year-Old Lung-Transplanted Cystic Fibrosis Patient

Compilation of Escherichia coli K-12 outer membrane phage receptors - their function and some historical remarks

(2020) Klaus Hantke   FEMS MICROBIOLOGY LETTERS

Safety of bacteriophage therapy in severe Staphylococcus aureus infection

(2020) Aleksandra Petrovic Fabijan et al.   Nature Microbiology

Bacteriophages: it's a medicine, Jim, but not as we know it

(2020) Jean-Paul Pirnay et al.   LANCET INFECTIOUS DISEASES

Genotypic to Phenotypic Resistance Discrepancies Identified Involving β-Lactamase Genes, blaKPC, blaIMP, blaNDM-1, and blaVIM in Uropathogenic Klebsiella pneumoniae

(2020) Umme Laila Urmi et al.   Infection and Drug Resistance

Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient

(2019) Nancy Law et al.   INFECTION

Phage therapy against Achromobacter xylosoxidan s lung infection in a patient with cystic fibrosis: a case report

(2018) N. Hoyle et al.   RESEARCH IN MICROBIOLOGY

Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains

(2018) Christine Rohde et al.   Viruses-Basel

Innovations for the treatment of a complex bone and joint infection due to XDR Pseudomonas aeruginosa including local application of a selected cocktail of bacteriophages

(2018) Tristan Ferry et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial

(2018) Patrick Jault et al.   LANCET INFECTIOUS DISEASES

Salvage ‘DAIR’ (debridement, antibiotics and implant retention) with local injection of a selected cocktail of bacteriophages: is it an option for an elderly patient with relapsing S. aureus prosthetic-joint infection?

(2018) Tristan Ferry et al.   Open Forum Infectious Diseases

The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa -infected airways

(2017) Stephanie Trend et al.   Journal of Cystic Fibrosis

Anti-Tuberculosis Bacteriophage D29 Delivery with a Vibrating Mesh Nebulizer, Jet Nebulizer, and Soft Mist Inhaler

(2017) Nicholas B. Carrigy et al.   PHARMACEUTICAL RESEARCH

Bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomized, placebo-controlled, double-blind clinical trial

(2017) Lorenz Leitner et al.   BMC Urology

Epidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literature

(2016) Piet Cools et al.   BMC MICROBIOLOGY

Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences

(2016) Nina Chanishvili   Current Drug Delivery

Phenotypic Resistance and the Dynamics of Bacterial Escape from Phage Control

(2014) James J. Bull et al.   PLoS One

First genome sequences of Achromobacter phages reveal new members of the N4 family

(2014) Johannes Wittmann et al.   Virology Journal

Efficacy of Bacteriophage Therapy in Experimental Sepsis and Meningitis Caused by a Clone O25b:H4-ST131 Escherichia coli Strain Producing CTX-M-15

(2012) Flavie Pouillot et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Experimental Phage Therapy in TreatingKlebsiella pneumoniae-Mediated Liver Abscesses and Bacteremia in Mice

(2011) Chih-Hsin Hung et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

(2011) A.-P. Magiorakos et al.   CLINICAL MICROBIOLOGY AND INFECTION

Rapid genotyping of Achromobacter xylosoxidans, Acinetobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolates using melting curve analysis of RAPD-generated DNA fragments (McRAPD)

(2011) Pieter Deschaght et al.   RESEARCH IN MICROBIOLOGY

A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistantPseudomonas aeruginosa; a preliminary report of efficacy

(2009) A. Wright et al.   CLINICAL OTOLARYNGOLOGY

Bacteriophage Therapy ofSalmonella enterica:A Fresh Appraisal of Bacteriophage Therapy

(2009) Rosanna Capparelli et al.   JOURNAL OF INFECTIOUS DISEASES

Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials

(2009) Maya Merabishvili et al.   PLoS One